JPMorgan Chase & Co’s Orchestra BioMed OBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.26K | Sell |
470
-11,482
| -96% | -$30.8K | ﹤0.01% | 5712 |
|
|
2025
Q1 | $51.2K | Sell |
11,952
-37,453
| -76% | -$160K | ﹤0.01% | 5025 |
|
|
2024
Q4 | $198K | Buy |
49,405
+38,535
| +355% | +$154K | ﹤0.01% | 4536 |
|
|
2024
Q3 | $55.9K | Sell |
10,870
-450
| -4% | -$2.31K | ﹤0.01% | 4950 |
|
|
2024
Q2 | $92.3K | Buy |
11,320
+5,124
| +83% | +$41.8K | ﹤0.01% | 4630 |
|
|
2024
Q1 | $32.7K | Sell |
6,196
-3,410
| -35% | -$18K | ﹤0.01% | 5105 |
|
|
2023
Q4 | $87.7K | Hold |
9,606
| – | – | ﹤0.01% | 4830 |
|
|
2023
Q3 | $83.8K | Buy |
9,606
+6,202
| +182% | +$54.1K | ﹤0.01% | 4714 |
|
|
2023
Q2 | $23.8K | Buy |
+3,404
| New | +$23.8K | ﹤0.01% | 5008 |
|